https://www.selleckchem.com/pr....oducts/upadacitinib.
s with episodic spasms and normal tendon reflexes without simultaneous cocontraction of limb agonist/antagonist muscles who were not taking SSRI or SNRI antidepressants. This study provides Class IV evidence that, for a subset of people with SPSD, autologous nonmyeloablative HSCT improves outcomes. NCT02282514. NCT02282514. To describe the spectrum, treatment, and outcome of cranial nerve disorders associated with immune checkpoint inhibitor (Cn-ICI). This nationwide retrospective cohort study on Cn-ICI (2015-2019) was conducted us
Like
Comment
Share
